Computer Aided Drug Design in Industrial Research (= Ernst Schering Research Foundation, Workshop 15).

Herrmann, E.C. - R. Franke (Ed.):

ISBN 10: 3540590412 / ISBN 13: 9783540590415

Published by Springer Verlag, Berlin 1995., 1995

About this Item

21,5 x 15 cm. Dark grey original hardback. XIII, (I), 252 pages with some b/w figures. Top of spine is bumped very slightly, a name inside the frontcover (see text below). Clean copy in good condition. Aus dem Besitz des Professors Hans-Jürgen Quabbe (Klinikum Berlin Steglitz / FU Berlin) mit seinem Namen im Innendeckel. / Preowner: Professors Hans-Jürgen Quabbe (Klinikum Berlin Steglitz / FU Berlin) // 2nd ISBN: 0387590412 -- Bitte Portokosten außerhalb EU erfragen! / Please ask for postage costs outside EU! / S ' il vous plait demander des frais de port en dehors de l ' UE! // Bitte beachten Sie auch unsere Fotos! / Please also note our photos! / Veuillez noter nos photos -- Lesen Sie etwas Schönes auf einer Bank in der Frühlingssonne! Wir haben die passende Lektüre. -- Wir kaufen Ihre werthaltigen Bücher! Chem.

Seller Inventory # 618791

Bibliographic Details

• Title: Computer Aided Drug Design in Industrial Research (= Ernst Schering Research Foundation, Workshop 15).
• Publisher: Springer Verlag, Berlin 1995.
• Publication Date: 1995
• Language: English
• ISBN 10: 3540590412
• ISBN 13: 9783540590415
• Binding: Hardcover
• Edition: 1st Edition
• Seller catalogs:
  • Chemie

About this title

Synopsis

The Ernst Schering Research Foundation sponsored its 15th workshop in Berlin on October 19-21, 1994. Leading scientists from Europe and North America were invited to discuss computer-aided drug design in industrial research. Computer-aided drug design is a very exciting field and an intellec­ tual challenge, like playing chess. But these reasons are no longer suf­ ficient to justify using this method in industry, if they ever were. Fig. 1. The participants of the workshop VI Preface Therefore, when we, together with Prof. Hoyer, started to think about this workshop, our intentions quickly became clear. We were not so much interested in the very latest developments of methods or in computer-aided drug design itself - enough conferences have dealt with these topics. However, we were very interested in the usefulness and limitations of computer-aided drug design in the indu­ strial research process. A lot has changed in the pharmaceutical industry recently. These changes are gaining momentum, so it is the right time to think about the role of computer-aided drug design in this changing environment.